Pak Fah Yeow International Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pak Fah Yeow International Limited with three other
pharmaceutical manufacturers in North America:
Cara Therapeutics Inc
of UNITED STATES
(2019
sales of $19.89 million
of which 100%
was Pharmaceutical),
Verastem Inc
of UNITED STATES
($17.46 million
of which 100%
was Pharmaceuticals preparation), and
Xoma Corporation
which is
also
based in UNITED STATES
($18.37 million
of which 100%
was Biopharmaceutical Pro).
Sales Analysis.
Pak Fah Yeow International Limited reported sales of 18.86 million Bermudian Dollars (US$18.86 million)
for the
year ending
December of 2019.
This
represents
an
increase of 4.8%
versus 2018, when the company's sales were 17.99 million Bermudian Dollars.
Despite this increase, sales are still
well
below the level achieved in 2017, when Pak Fah Yeow International Limited
reported sales of 22.87 million Bermudian Dollars.
Sales of Treasury Investment saw an increase
that was more than double the company's growth rate: sales were up
93.2% in 2019, from
66,214.02 Bermudian Dollars to 127,905.30 Bermudian Dollars.